SCHEMBL1949588

SCHEMBL1949588

COc1ccc(C=O)cc1OCC(=O)OC(C)C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
TSHR P16473 1/20 0.55
POLB P06746 1/20 0.53
FDPS P14324 1/20 0.52
KDM4E B2RXH2 1/20 0.52
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
AOX1 Q06278 1/20 0.48
TRIM24 O15164 1/20 0.48
HPGD P15428 1/20 0.48
ALDH5A1 P51649 1/20 0.48
ABAT P80404 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
TRIM33 Q9UPN9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677018 0.86 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL1950408 0.84 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2POLBFDPSKDM4E
SCHEMBL1949645 0.83 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL2560660 0.81 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL29956334 0.81 POLB (0.65) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL5246469 0.81 POLB (0.65) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL2284391 0.80 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL2556412 0.80 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL2559017 0.80 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2TSHRPOLBFDPS
SCHEMBL2555761 0.78 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2TSHRPOLBFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507237-A1 IMIDAZOQUINOLINES WHICH ACT VIA TOLL - LIKE RECEPTORS (TLR) Dainippon Sumitomo Pharma Co., Ltd. (JP) 2012-10-10 EP disclosed
WO-2011068233-A1 IMIDAZOQUINOLINES WHICH ACT VIA TOLL - LIKE RECEPTORS (TLR) DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-06-09 WO disclosed
US-20110136801-A1 Novel Compounds DAINIPPON SUMITOMO PHARMA CO. LTD. (JP) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136801-A1 Novel Compounds C1R, RB1, CNKSR1 ALDH1A1 173/4885SMN1; SMN2 1340/4885TSHR 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.